Literature DB >> 12062042

Differential activation of individual subunits in heteromeric kainate receptors.

Geoffrey T Swanson1, Tim Green, Ryuichi Sakai, Anis Contractor, Wesley Che, Hisao Kamiya, Stephen F Heinemann.   

Abstract

Neuronal kainate receptors are assembled from subunits with dissimilar specificities for agonists and antagonists. The composite biophysical behavior of heteromeric kainate receptors is determined by intersubunit interactions whose nature is unclear. Here we use dysiherbaine, a selective kainate receptor agonist, to show that GluR5 subunits assembled in heteromeric GluR5/KA-2 kainate receptor complexes can gate current without concomitant activation of their partner KA-2 subunits. A long-lasting interaction between dysiherbaine and GluR5 subunits elicits a tonic current from GluR5/KA-2 receptors; subsequent cooperative gating of KA-2 subunits can be elicited by both agonists, such as glutamate, and some classically defined antagonists, such as CNQX. This study demonstrates that each type of subunit within a heteromeric kainate receptor contributes a distinct conductance upon activation by agonist binding, and therefore provides insight into the biophysical function of ionotropic glutamate receptors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12062042     DOI: 10.1016/s0896-6273(02)00676-1

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  32 in total

Review 1.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

2.  Channel-opening kinetic mechanism for human wild-type GluK2 and the M867I mutant kainate receptor.

Authors:  Yan Han; Congzhou Wang; Jae Seon Park; Li Niu
Journal:  Biochemistry       Date:  2010-11-02       Impact factor: 3.162

3.  Identification of critical functional determinants of kainate receptor modulation by auxiliary protein Neto2.

Authors:  Theanne N Griffith; Geoffrey T Swanson
Journal:  J Physiol       Date:  2015-09-20       Impact factor: 5.182

4.  Concanavalin-A reports agonist-induced conformational changes in the intact GluR6 kainate receptor.

Authors:  Anne-Marie L Fay; Derek Bowie
Journal:  J Physiol       Date:  2006-01-26       Impact factor: 5.182

5.  Modulation of homomeric and heteromeric kainate receptors by the auxiliary subunit Neto1.

Authors:  Janet L Fisher; David D Mott
Journal:  J Physiol       Date:  2013-06-24       Impact factor: 5.182

6.  Crosslinking the ligand-binding domain dimer interface locks kainate receptors out of the main open state.

Authors:  Bryan A Daniels; Elizabeth D Andrews; Mark R P Aurousseau; Michael V Accardi; Derek Bowie
Journal:  J Physiol       Date:  2013-05-27       Impact factor: 5.182

Review 7.  Recent progress in neuroactive marine natural products.

Authors:  Ryuichi Sakai; Geoffrey T Swanson
Journal:  Nat Prod Rep       Date:  2014-01-17       Impact factor: 13.423

8.  Synthesis of the dysiherbaine tetrahydropyran core employing a tethered aminohydroxylation reaction.

Authors:  Jamie L Cohen; A Richard Chamberlin
Journal:  Tetrahedron Lett       Date:  2007-04-02       Impact factor: 2.415

9.  Full domain closure of the ligand-binding core of the ionotropic glutamate receptor iGluR5 induced by the high affinity agonist dysiherbaine and the functional antagonist 8,9-dideoxyneodysiherbaine.

Authors:  Karla Frydenvang; L Leanne Lash; Peter Naur; Pekka A Postila; Darryl S Pickering; Caleb M Smith; Michael Gajhede; Makoto Sasaki; Ryuichi Sakai; Olli T Pentikaïnen; Geoffrey T Swanson; Jette S Kastrup
Journal:  J Biol Chem       Date:  2009-03-18       Impact factor: 5.157

10.  Pharmacological activity of C10-substituted analogs of the high-affinity kainate receptor agonist dysiherbaine.

Authors:  L Leanne Lash-Van Wyhe; Pekka A Postila; Koichi Tsubone; Makoto Sasaki; Olli T Pentikäinen; Ryuichi Sakai; Geoffrey T Swanson
Journal:  Neuropharmacology       Date:  2009-12-04       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.